In carbon tetrachloride–induced rat hepatic fibrosis model, the anti-fibrotic effect of (-)-epigallocatechin-3-gallate (EGCG) has been demonstrated to be associated with its effect in down-regulation of IGF-1R expression 29. The gene discussed is IGF1R; the disease is Hepatic fibrosis.